benphothiamine has been researched along with pimagedine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imaizumi, T; Yamagishi, S | 1 |
| Castilho, G; de Souza Pinto, R; Inada, NM; Machado-Lima, A; Nakandakare, ER; Paim, BA; Passarelli, M; Vercesi, AE | 1 |
| Engelen, L; Schalkwijk, CG; Stehouwer, CD | 1 |
2 review(s) available for benphothiamine and pimagedine
| Article | Year |
|---|---|
[Progress on the drug therapy for diabetic microangiopathies: AGE inhibitors].
Topics: Animals; Clinical Trials as Topic; Depression, Chemical; Diabetic Angiopathies; Glycation End Products, Advanced; Guanidines; Humans; Oxidative Stress; Pyridoxamine; Thiadiazoles; Thiamine; Thiazoles; Thiazolidines | 2005 |
Current therapeutic interventions in the glycation pathway: evidence from clinical studies.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Enzyme Inhibitors; Evidence-Based Medicine; Female; Glycation End Products, Advanced; Guanidines; Humans; Hyperglycemia; Male; Pyridoxamine; Thiamine; Thiazoles; Treatment Outcome | 2013 |
1 other study(ies) available for benphothiamine and pimagedine
| Article | Year |
|---|---|
Inhibition of macrophage oxidative stress prevents the reduction of ABCA-1 transporter induced by advanced glycated albumin.
Topics: Animals; Antioxidants; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Cells, Cultured; Glycation End Products, Advanced; Guanidines; Humans; Macrophages; Mice; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Serum Albumin; Serum Albumin, Human; Thiamine | 2012 |